Tradestie Institutional Equity Comparison Engine

CVS vs CMCSA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CMCSA Overall Edge

CMCSA Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Comcast Corp (CMCSA) driven by superior Valuation, Growth & Margin, Options & Structure while CVS counters with relative strength in Momentum & Technical. Fundamentally, CVS trades at 9.3x Forward P/E with 3.1% operating margin (+5.4% YoY revenue) versus CMCSA at 7.1x Forward P/E and 14.7% operating margin (-6.1% YoY). In options structure, CVS sits in CONSOLIDATION (69th %ile IV; Dealer Gamma Walls on Pro) against CMCSA sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CMCSA
CVS 9.3x vs CMCSA 7.1x Fwd P/E
Growth & Margin Winner CMCSA
Op Margin 3.1% vs 14.7% ยท YoY +5.4% vs -6.1%
Momentum & Technical Winner CVS
1Y +5.6% vs -7.3% ยท 52W Pos 28% vs 36%
Options & Structure Winner CMCSA
CONSOLIDATION (69th %ile IV) vs CONSOLIDATION (30th %ile IV)
CVS NYSE
Cvs Health Corporation
Retail-Drug Stores And Proprietary Stores
$80.84
+1.0% 1D
Market Cap $102.4B
1M Return -14.44%
1Y Return +5.6%
Forward P/E 9.3x
Unified AI Score
62.6 / 100 BUY
Tech 65.0 Fund 62.0 Flow 58.0 Mom 60.0
CMCSA NASDAQ
Comcast Corp
Cable & Other Pay Television Services
$24.90
+0.16% 1D
Market Cap $88.3B
1M Return +9.02%
1Y Return -7.33%
Forward P/E 7.1x
Unified AI Score
32.8 / 100 SELL
Tech 20.0 Fund 44.0 Flow 59.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVS +5.6% CMCSA -7.33% Spread: +12.93 pp (CVS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CVS Revenue CMCSA Revenue CVS Op. Margin CMCSA Op. Margin Margin Edge
FY2018 $193.9B $94.5B 2.1% 20.1% CMCSA
FY2019 $256.8B $108.9B 4.7% 19.4% CMCSA
FY2020 $268.7B $103.6B 5.2% 16.9% CMCSA
FY2021 $292.1B $116.4B 4.6% 17.9% CMCSA
FY2022 $322.5B $121.4B 2.5% 11.6% CMCSA
FY2023 $357.8B $121.6B 3.8% 19.2% CMCSA
FY2024 $372.8B $123.7B 2.3% 18.8% CMCSA
FY2025 $402.1B $123.7B 1.2% 16.7% CMCSA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVS (4) vs CMCSA (6)
Institutional Metric CVS CMCSA Criterion Row Winner
Market Capitalization Scale $102.4B $88.3B Larger Scale CVS
Trailing P/E Ratio Valuation 9.3x 7.9x Lower Multiple CMCSA
Forward P/E Ratio Valuation 9.3x 7.1x Lower Multiple CMCSA
Revenue Growth (YoY) Growth +5.4% -6.1% Higher Growth CVS
Operating Margin (TTM) Profitability 3.1% 14.7% Higher Margin CMCSA
Net Profit Margin Profitability 2.6% 9.2% Higher Margin CMCSA
Return on Equity (ROE) Capital Efficiency 14.4% 11.4% Higher ROE CVS
52-Week Range Position Momentum 28% ($70โ€“$111) 36% ($20โ€“$33) Stronger Trend CMCSA
Beta / 30D Volatility Risk Regime -0.03ฮฒ ยท 54% Vol -0.01ฮฒ ยท 32% Vol Lower Realized Risk CMCSA
Unified Institutional Score Composite Signal 62.6 / 100 (BUY) 32.8 / 100 (SELL) Higher Composite CVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVS vs CMCSA Buy Guide
CVS CONSOLIDATION
104d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 69th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live CVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CMCSA CONSOLIDATION
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CMCSA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVS nor CMCSA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.